Relationship between baseline characteristics and response to risedronate treatment for osteoporosis: data from three Japanese phase III trials

SUMMARY: We evaluated the influence of baseline age, bone mineral density (BMD), and serum levels of vitamin D on the response to risedronate treatment. Risedronate consistently increased BMD, but our results suggest vitamin D supplementation may be necessary to achieve optimal treatment effect. Fur...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawatari, T., Muraoka, R., Iwamoto, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357292/
https://www.ncbi.nlm.nih.gov/pubmed/27900428
http://dx.doi.org/10.1007/s00198-016-3848-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357292/
https://www.ncbi.nlm.nih.gov/pubmed/27900428
http://dx.doi.org/10.1007/s00198-016-3848-4

Ejemplares similares